Viking Therapeutics, Inc. (VKTX)

NCM – Real vaqt narxi. Valyuta: USD

34.02

+0.22 (0.65%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

34.02

0.00 (0.00%)

Bozordan keyin: Aug 12, 2026, 4:15 PM EDT

08.08.2026

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Eli Lilly leads the GLP-1 market and could remain on top thanks to a deep pipeline. Viking Therapeutics' leading GLP-1 candidate looks very promising.

07.08.2026

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Viking Therapeutics (VKTX) maintains a Hold rating as competitive pressures intensify in the GLP-1 obesity drug space and key data catalysts approach. VKTX's lead asset VK2735 is in large Phase 3 VANQUISH trials, but efficacy expectations are high, and prior data is limited to a small, short Phase 2 study. A pivotal Q3 catalyst is the maintenance dosing study for VK2735; results could drive price volatility and influence funding needs amid high cash burn.

06.08.2026

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished

Cash burn and potential dilution are key investor concerns. The company's phase 3 trials remain on track, and investors are awaiting results from a maintenance trial this quarter.

Videolar

No Data

There is no data to display

Viking Therapeutics, Inc. (VKTX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Viking Therapeutics, Inc. (VKTX)

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished

Videolar

No Data

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished

Videolar

No Data

Search stocks

Viking Therapeutics, Inc. (VKTX)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Viking Therapeutics, Inc. (VKTX)

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished

Videolar

No Data

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished

Videolar

No Data